Discussions about global health issues related to drugs usually concentrate on affordability and availability, with limited consideration of other precipitating factors associated with distribution inequalities and efficacy in low-income countries. Inappropriate prescribing has a significant public health impact ranging from ineffective treatment of disease, drug resistance and potential harm to patients. We report on the problems associated with unsuitable prescribing of medication in an African setting.
BaxerresCLe HesranJY. Where do pharmaceuticals on the market originate? An analysis of the informal drug supply in Cotonou, Benin. Social Science & Medicine2011; 73: 1249–1256.
2.
GarubaHAKohlerJCHuismanAM. Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers. Global Health2009; 5: 14–14.
3.
AldhousP. Counterfeit pharmaceuticals: murder by medicine. Nature2005; 434: 132–136.
4.
AutaAOmaleSShalkurDAbiodunAH. Unused medicines in Nigerian households: types and disposal practices. J Pharmacol Pharmacother2011; 2: 195–196.
5.
AkandeTMAderibigbeSA. Influence of drug promotion on prescribing habits of doctors in a teaching hospital. Afr J Med Med Sci2007; 36: 207–211.
6.
PettiCAPolageCRQuinnTCRonaldARSandeMA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis2006; 42: 377–382.
7.
MohammedIChikwemJOGashauW. Determination by Widal agglutination of the baseline titre for the diagnosis of typhoid fever in two Nigerian states. Scand J Immunol1992; 36: 153–156.
8.
PeltzmanS. An evaluation of consumer protection legislation: the 1962 drug amendments. J Political Econ1973; 81: 1049–1091.
9.
BassiPUOsakweAIIsahA. Safety of Artemisinin-based combination therapies in Nigeria: a cohort event monitoring study. Drug Safety2013; 36(9): 747–756.
